share_log

BMO Capital Upgrades Amgen to Outperform, Raises Price Target to $326

Benzinga ·  Dec 19, 2023 05:13

BMO Capital analyst Evan David Seigerman upgrades Amgen (NASDAQ:AMGN) from Market Perform to Outperform and raises the price target from $286 to $326.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment